Background: Endodontic flare-up signifies pain and/or swelling seen within a few days after an endodontic appointment by patients requiring an emergency. These are undesirable and unwanted as they cause great discomfort to the subjects and stress to the operator due to swelling and pain.
Aims: This study aims to determine the flare-up incidence and associated risk factors during endodontic treatment.
Methods: The present retrospective study assessed 1000 patients of both genders for endodontic flare-ups. Flare-up cases were patients having swelling or pain within 1-3 days after a root canal appointment and needing an emergency visit for relieving the symptoms. After data recording, it was subjected to statistical analysis to assess related factors, flare-up cause, and incidence rate using Fisher's exact test and chi-square test.
Results: In the present study, the incidence rate of flare-ups is 9.4%. The majority of flare-ups were in the molar teeth followed by the anterior teeth and 6.7% (n=30) of the premolar teeth. For the number of canals, it was seen in 13.6% (n=24) of cases with multiple canals, 5.5% (n=12) of cases with two canals, and 9.6% (n=58) of cases with a single canal. In patients with no medical history, flare-ups were significantly less compared to patients with medical history (p<0.001). A significantly higher number of flare-ups were in the teeth having pulp necrosis with periapical lesions with 45.9% (n=34) (p<0.001).
Conclusion: Flare-ups are commonly seen in multiple canal teeth having pulp necrosis with periapical lesions with an associated medical history, with females being more prone to endodontic flare-up cases.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747067 | PMC |
| http://dx.doi.org/10.7759/cureus.31424 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Self-Reported Delayed Adverse Events and Flare Following COVID-19 Vaccination Among Patients With Autoimmune Rheumatic Disease (AIRD) in Malaysia: Results From the COVAD-2 Study.
Int J Rheum Dis
January 2025
Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Objectives: To determine the prevalence of self-reported delayed adverse events (DAEs), major AEs, and flares following COVID-19 vaccinations among patients with autoimmune rheumatic diseases (AIRDs) in Malaysia.
Methodology: An electronically validated survey from the COVID-19 vaccination in autoimmune diseases (COVAD) study group was distributed in July 2021 to patients with autoimmune diseases and healthy controls (HCs). The survey collected data on DAEs (any AE that persisted or occurred after 7 days of vaccination), any early or delayed major adverse events (MAEs), and flares following COVID-19 vaccination.
Prevalence and clinical significance of pre- and post-bronchodilator airflow obstruction in COPD patients.
Pulm Pharmacol Ther
December 2024
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Republic of Korea. Electronic address:
Article Synopsis
- - The study analyzed 3,252 COPD patients in South Korea to evaluate the prevalence and significance of airflow obstruction before and after bronchodilator treatment, revealing that most patients (96.2%) fell into the pre-bronchodilator and post-bronchodilator obstruction category.
- - Over three years, approximately 21.6% of patients faced moderate-to-severe exacerbations, but the risk was not statistically significant after adjustments; other outcomes, like GOLD group progression and FEV₁ decline, showed no major differences linked to bronchodilator treatment.
- - The findings suggest that pre-bronchodilator spirometry is effective for screening COPD, though the initial higher exacerbation risk associated with combined obstruction faded upon further
The Incidence and Predictive Factors of Thromboembolism During Hospitalizations for Inflammatory Bowel Disease Flare-Ups: A Retrospective Cohort Study in Taiwan.
J Eval Clin Pract
November 2024
Chang Gung Inflammatory Bowel Disease Center, Linkou, Taoyuan, Taiwan.
Background/aims: Thromboembolism (TE) notably increase morbidity and mortality among inflammatory bowel disease (IBD) patients. Despite ECCO's 2024 guidelines advocating routine anticoagulant prophylaxis, its application in Asia remains inconsistent due to a lack of regional studies. This research investigates the incidence and predictors of TE during IBD-related hospitalizations in Taiwan, aiming to improve prevention strategies.
View Article and Find Full Text PDFWhat happens between first symptoms and first acute exacerbation of COPD - observational study of routine data and patient survey.
Health Soc Care Deliv Res
October 2024
School of Public Health, Imperial College London, London, UK.
Article Synopsis
- - The study focuses on understanding the diagnosis process and management of Chronic Obstructive Pulmonary Disease (COPD) in the UK, where nearly 400 million people are affected globally, making it a significant health issue.
- - Researchers tracked patient data over three time periods to analyze how long it takes to get diagnosed with COPD after symptoms appear, as well as the frequency of acute exacerbations—a period when symptoms worsen significantly.
- - The results indicated that most diagnoses happen in primary care and revealed variations in how different practices comply with established guidelines; the study highlights the need for improved adherence to these guidelines in COPD management.
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for recurrent nephrolithiasis among patients with pre-existing nephrolithiasis or gout: target trial emulation studies.
BMJ
October 2024
Rheumatology and Allergy Clinical Epidemiology Research Center, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA, USA
Objective: To emulate target trials comparing recurrence of nephrolithiasis among patients with pre-existing nephrolithiasis (overall and stratified by concomitant gout) initiating sodium-glucose cotransporter-2 (SGLT-2) inhibitors versus an active comparator.
Design: Target trial emulation studies.
Setting: Canadian population database, January 2014 to June 2022.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!